Live Demo:
This is a live DrugChatter demonstration using real AI-generated drug queries and analysis.
Want to see how your drug is represented by AI?
Contact DrugChatter
ivermectin
Brand Visibility Tracking
How this brand shows up in AI chatbot answers — presence, position, sentiment, and how it stacks up against competitors.
–
Score / 100
Latest check
Weighted composite of presence, position, sentiment, and recommendation strength across tracked prompts.
Presence
–
Avg. position
–
Lower is betterSentiment
–
Recommendation mix — latest check
How the brand was framed across the latest tracked prompts.
Competitive landscape — latest check
Visibility vs. sentiment. Bubble size reflects rank position (bigger = higher-ranked).
Best known for — latest check
Strongyloidiasis
Parasite infections and skin conditions involving mites, commonly rosacea
Core Claims — latest check
Ivermectin is used for specific parasitic infections.
Both products contain ivermectin, but have different labeled uses, formulations, and dose schedules.
Brand and generic products use different naming and manufacturer labels.
The active ingredient is the same, but inactive ingredients can differ.
Products can differ in appearance, dosage form, and strength or concentration.
Differentiators — latest check
The response says the active ingredient is the same while excipients and product presentation can differ.
Has a strong role in other helminths, especially Strongyloides, and certain endemic settings.
Is associated with specific parasite groups rather than being a universal alternative for intestinal worms.
Tablets are designed to achieve systemic levels; topical cream is designed for local skin effect.
Marketing tends to differ by formulation, strength, indication, and regulatory approval or labels.
Competitor comparison — latest check
| Brand | Visibility | Sentiment | Position | Recommended |
|---|
30-day composite trends
Score
Overall composite score, per day.
Visibility vs. sentiment
Two lenses on the same conversations — how much the brand shows up, and how it's spoken about.
Average rank position
Where the brand lands among all brands mentioned, in reading order. Lower is better.
Recent checks
| Date | Score | Visibility | Position | Sentiment |
|---|---|---|---|---|
| Oct 16, 2026 | 44 | 70 | 0 | 47 |
| Oct 17, 2026 | 55 | 73 | 0 | 49 |
| Oct 18, 2026 | 43 | 66 | 1 | 47 |
| Oct 19, 2026 | 45 | 63 | 0 | 50 |
| Oct 20, 2026 | 49 | 65 | 0 | 51 |
| Oct 21, 2026 | 55 | 74 | 0 | 50 |
| Oct 22, 2026 | 58 | 80 | 0 | 50 |
| Oct 23, 2026 | 56 | 66 | 1 | 49 |
| Oct 24, 2026 | 48 | 78 | 0 | 50 |
| Oct 25, 2026 | 54 | 68 | 1 | 50 |
| Oct 26, 2026 | 52 | 70 | 0 | 47 |
| Oct 27, 2026 | 50 | 69 | 0 | 51 |
| Oct 28, 2026 | 57 | 76 | 0 | 49 |
| Oct 29, 2026 | 58 | 75 | 0 | 50 |
| Oct 30, 2026 | 52 | 75 | 0 | 50 |
| Oct 31, 2026 | 56 | 73 | 0 | 50 |
| Nov 1, 2026 | 50 | 66 | 0 | 50 |
| Nov 2, 2026 | 51 | 68 | 0 | 50 |
| Nov 3, 2026 | 52 | 74 | 0 | 50 |
| Nov 4, 2026 | 55 | 67 | 0 | 51 |
| Nov 5, 2026 | 54 | 70 | 1 | 50 |
| Nov 6, 2026 | 59 | 75 | 1 | 50 |
| Nov 7, 2026 | 52 | 73 | 0 | 50 |
| Nov 8, 2026 | 53 | 64 | 0 | 51 |
| Nov 9, 2026 | 48 | 70 | 0 | 46 |
| Nov 10, 2026 | 61 | 75 | 0 | 50 |
| Nov 11, 2026 | 54 | 74 | 0 | 47 |
| Nov 12, 2026 | 51 | 69 | 1 | 53 |
| Nov 13, 2026 | 54 | 69 | 0 | 49 |